Diagnostic and Therapeutic Advances in Paediatrics 2019
DOI: 10.1136/thorax-2019-btsabstracts2019.67
|View full text |Cite
|
Sign up to set email alerts
|

S61 Onasemnogene abeparvovec gene-replacement therapy (GRT) for spinal muscular atrophy type 1 (SMA1): preliminary pulmonary and ventilatory findings from the phase 3 study (STR1VE)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles